Isis was Goddess of Life, and inspiration for Isis Pharmaceuticals
- Posted by Greg Harmon
- on November 19th, 2015
Talk about a company that is going through a crisis. Isis Pharmaceuticals ($ISIS) thought they named themselves after the Egyptian Goddess of Magic and Life. Well that has sure changed. Time for a new name maybe?
The stock had a rough 7 months, running lower from a peak near 80. The final blow was the deep fall with the rest of the healthcare and pharma space in September. Since then it found a bottom and has moved higher, rising from the ashes. Perhaps they should rename the company Phoenix?
After the move up from 37 it is currently pausing in a bull flag under 65. This is what makes it interesting. The Measured Move would target 87.5. As it gathers energy for that move the momentum indicators are supportive of a move higher. The RSI is strong in the bullish zone, and the MACD has pulled back in the flag but not even crossed down. There is plenty of room to the upside int eh Bollinger Bands® as well. Look for a break over 62.5 to confirm the move higher out of the flag and ride Isis (yes I like Phoenix) higher.
Get my ebook, Markets for 2015 and Beyond, a long term forecast with all proceeds going to charity.
Want to learn more about Dragonfly Capital Views?
Dragonfly Capital Views Performance Through September 2015 and sign up here
If you like what you see above sign up for deeper analysis and trading strategy by using the Get Premium button above. As always you can see details of individual charts and more on my StockTwits page.
The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.
blog comments powered by Disqus-
Gregory W. Harmon CMT, CFA, has traded since 1986 and held senior positions including Head of Global Trading, Head of Product Development, Head of Strategy and Director of Equity. (More)

